Course - First Principles in Binding Kinetics: Towards Predicting Structure-Kinetics Relationships

PRLog (Press Release) - Feb 09, 2012 -
This course will address the questions on “why should I care about kinetics?” and “how can I understand and predict Structure-Kinetics relationships?”  We will first review the role of binding kinetics in drug action and then focus on the particular case of protein-ligand non-covalent complexes, reviewing what is known so far about the structural determinants of binding kinetics. This course will help you with a better understanding and increased awareness of current state of the chemistry and pharmacology of binding kinetics.

Instructors:
David Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)

Xavier Barril, Ph.D., ICREA Research Professor, Physical Chemistry Department, University of Barcelona

Date: June 6, 2012
Time: 6:00-8:00 pm
Place: Royal Sonesta Hotel Boston, Cambridge, Massachusetts

For more details and to register for this course and/or the Structure-Based Drug Design conference, visit http://www.healthtech.com/sbd.

About Cambridge Healthtech Institute (http://www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Bio-IT World: (http://www.bio-itworld.com)

Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com), Bio-IT World magazine is a bimonthly publication that life science and IT/informatics professionals continuously reference to find information, news, and commentary on indispensable technologies and business strategies.  Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Cambridge Healthtech Media Group also hosts daily news and opinion at http://www.bio-itworld.com, a variety of e-newsletters, and a rich compendium of webinars and web symposia. Cambridge Healthtech Media Group is based in Needham, Mass.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com